GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Flerie AB (OSTO:FLERIE) » Definitions » FCF Yield %

Flerie AB (OSTO:FLERIE) FCF Yield % : -4.36 (As of Sep. 21, 2024)


View and export this data going back to 2016. Start your Free Trial

What is Flerie AB FCF Yield %?

FCF Yield % is calculated as Free Cash Flow divided by Market Capitalization. It is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.

As of today, Flerie AB's Trailing 12-Month Free Cash Flow is kr-145.69 Mil, and Market Cap is kr3,337.34 Mil. Therefore, Flerie AB's FCF Yield % for today is -4.36%.

The historical rank and industry rank for Flerie AB's FCF Yield % or its related term are showing as below:

OSTO:FLERIE' s FCF Yield % Range Over the Past 10 Years
Min: -41.06   Med: -15.94   Max: -0.26
Current: -4.36


During the past 10 years, the highest FCF Yield % of Flerie AB was -0.26%. The lowest was -41.06%. And the median was -15.94%.

OSTO:FLERIE's FCF Yield % is ranked better than
71.37% of 1537 companies
in the Biotechnology industry
Industry Median: -13.28 vs OSTO:FLERIE: -4.36

Flerie AB's FCF Margin % for the quarter that ended in Jun. 2024 was -17,200.00%.


Flerie AB FCF Yield % Historical Data

The historical data trend for Flerie AB's FCF Yield % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Flerie AB FCF Yield % Chart

Flerie AB Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
FCF Yield %
Get a 7-Day Free Trial Premium Member Only Premium Member Only -16.47 -17.45 -13.38 -28.76 -27.85

Flerie AB Quarterly Data
Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24
FCF Yield % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 113.30 -44.86 -137.87 -86.63 -1.87

Competitive Comparison of Flerie AB's FCF Yield %

For the Biotechnology subindustry, Flerie AB's FCF Yield %, along with its competitors' market caps and FCF Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Flerie AB's FCF Yield % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Flerie AB's FCF Yield % distribution charts can be found below:

* The bar in red indicates where Flerie AB's FCF Yield % falls into.



Flerie AB FCF Yield % Calculation

FCF Yield % is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.

Flerie AB's FCF Yield % for the fiscal year that ended in Dec. 2023 is calculated as

FCF Yield %=Free Cash Flow / Market Cap
=-37.977 / 136.368128
=-27.85%

Flerie AB's annualized FCF Yield % for the quarter that ended in Jun. 2024 is calculated as

FCF Yield %=Free Cash Flow * Annualized Factor / Market Cap
=-17.2 * 4 / 3684.73408
=-1.87%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Flerie AB FCF Yield % Explanation

Similar to Earnings Yield %, FCF Yield % is financial solvency ratio. A lower ratio suggests a less attractive investment, indicating that investors might not receive substantial returns in proportion to their investment. Conversely, a high free cash flow yield signals that a company generates sufficient cash to comfortably meet its debts, obligations, and dividend payments, making it a promising investment choice.


Flerie AB FCF Yield % Related Terms

Thank you for viewing the detailed overview of Flerie AB's FCF Yield % provided by GuruFocus.com. Please click on the following links to see related term pages.


Flerie AB Business Description

Traded in Other Exchanges
Address
Berzelius vag 13, Solna, SWE, 171 65
InDex Pharmaceuticals Holding AB is a pharmaceutical company focusing on immunological diseases with great medical needs for new treatment options. The company's main asset is the drug candidate cobitolimod, which is being evaluated in the phase III study as a treatment for moderate to severe ulcerative colitis - a disabling, chronic inflammation of the colon. It has also developed a platform of patent-protected substances, so-called DNA-based Immunomodulatory Sequences, with the potential to be used in the treatment of various immunological diseases.

Flerie AB Headlines

No Headlines